Invivyd IVVD
NASDAQ IVVD
$0.83 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Invivyd (IVVD) Other Accumulated Expenses (2022 - 2026)

Invivyd's (IVVD) quarterly Other Accumulated Expenses came in at $71000.0 in Q2 2026, up 173.08% on a YoY basis from $26000.0 in Q2 2025, and up 36.54% quarter-over-quarter from $52000.0 in Q4 2025.

Analysis

Invivyd (IVVD) Other Accumulated Expenses (2022 - 2026) Analysis & Trends

Invivyd (IVVD) has reported Other Accumulated Expenses for 5 consecutive years, with $71000.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Other Accumulated Expenses rose 173.08% year-over-year to $71000.0; the trailing twelve-month figure through Jun 2026 stood at $71000.0 (up 173.08% YoY), and the FY2025 full-year result was $52000.0, up 92.59% from the prior year.
  • Other Accumulated Expenses grew to $71000.0 in Q2 2026 per IVVD's latest filing, from $52000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $71000.0 in Q2 2026 and bottomed at $20000.0 in Q3 2024.
  • Historically, Other Accumulated Expenses has averaged $39750.0 across 5 years, with a median of $36500.0 in 2023.
  • The sharpest annual moves came in 2023 and 2026: Other Accumulated Expenses tumbled 49.06% in 2023, then jumped 173.08% in 2026.
  • Over 5 years, Other Accumulated Expenses stood at $44000.0 in 2022, then decreased by 20.45% to $35000.0 in 2023, then declined by 22.86% to $27000.0 in 2024, then jumped by 92.59% to $52000.0 in 2025, then jumped by 36.54% to $71000.0 in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $71000.0, $52000.0, and $32000.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Invivyd 244.65 Mn 84.57 Mn 13.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 71,000.00
Dec 31, 2025 52,000.00
Sep 30, 2025 32,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 34,000.00
Dec 31, 2024 27,000.00
Sep 30, 2024 20,000.00
Jun 30, 2024 21,000.00
Mar 31, 2024 40,000.00
Dec 31, 2023 35,000.00
Sep 30, 2023 27,000.00
Jun 30, 2023 38,000.00
Mar 31, 2023 58,000.00
Dec 31, 2022 44,000.00
Sep 30, 2022 53,000.00
Jun 30, 2022 58,000.00